MEDICAL NEWS
1 in 9 American Men Infected With Oral HPV
5:00 PM CDT.
Vaccine provides protection, but number of boys getting shots remains low, researchers say
By Steven ReinbergHealthDay Reporter Read article
- Breast Cancer More Lethal for Blacks Than Whites
- With Skin Cancer Surgery, Insurance Matters
- Need Cancer Screening? Where You Work Matters
- More Women Choose Breast Reconstruction After Mastectomy
JOURNAL UPDATE
Online Ratings Not Aligned With Objective Quality Measures
7:00 PM CDT. In addition, consumer ratings are consistent across platforms for specialist physicians- Most Female Physicians Have Faced Sexist Patient Comments
- Model Predicts Cost-Effectiveness for Anal Lesion Treatment
- Serious Suffering Affects Almost Half of Those Who Die Yearly
MONTHLY JOURNAL SUMMARY
September 2017 Briefing - Hematology & Oncology
September 30, 2017. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
Bert Vogelstein explains cancer and the unavoidable replicative mutations
Bert Vogelstein, MD.
Investigators at Johns Hopkins University in Baltimore used complex mathematical modeling to track mutations driving abnormal cell growth for 32 types of cancer. From their calculations, the researchers believe that the bulk of cancers are caused by random DNA copying errors (replicative mutations).…
MEDICAL FOCUS
BRCA mutation testing
By Tamer M. Fouad, M.D.The BRCA gene test is used to identify mutations in either one of the two breast cancer susceptibility genes, BRCA1 and BRCA2. Women who have inherited…
DISCUSSION
RE: Aspirin Use as Treatment in Colorectal Cancer: Teaching an Old Dog New Tricks
By Jeffrey A. Gordon, M.D.Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
